Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Buprenorphine vs Morphine for NOWS Treatment Shortening
NCT04455802Phase 3Withdrawn
- Sponsor
- Women & Infants Hospital
- Start
- Oct 2020
- Primary completion
- May 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of buprenorphine in neonatal opioid withdrawal syndrome (NOWS), sponsored by Women & Infants Hospital. Planned start Oct 2020; status: withdrawn.
02
Drugs
buprenorphine
03
Conditions
neonatal opioid withdrawal syndrome (NOWS)
Beyond the preview
Go deeper on NCT04455802.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04455802.